Skip to main content

Advertisement

Log in

Surgical oncology

PBD—better stents in specialized centers are needed

  • News & Views
  • Published:

From Nature Reviews Clinical Oncology

View current issue Sign up to alerts

A recent trial concluded that preoperative biliary drainage (PBD) in patients with pancreatic head cancer increases complications but is unlikely to change clinical practice. The difference in the outcomes reported was because of excessive complications in the PBD group using plastic stents. We argue that these patients need treatment in regional pancreatic cancer centers using low-occlusion metal stents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Wang, Q., Gurusamy, K. S., Lin, H., Xie, X. & Wang, C. Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst. Rev, Issue 3. Art. No.: CD005444. doi:10.1002/14651858.CD005444.pub2 (2008).

  2. van der Gaag, N. A. et al. Preoperative biliary drainage for cancer of the head of the pancreas. N. Engl. J. Med. 362, 129–137 (2010).

    Article  CAS  PubMed  Google Scholar 

  3. Baron, T. H. & Kozarek, R. A. Preoperative biliary stents in pancreatic cancer--proceed with caution. N. Engl. J. Med. 362, 170–172 (2010).

    Article  CAS  PubMed  Google Scholar 

  4. Chen, V. K., Arguedas, M. R. & Baron, T. H. Expandable metal biliary stents before pancreaticoduodenectomy for pancreatic cancer: a Monte-Carlo decision analysis. Clin. Gastroenterol. Hepatol. 3, 1229–1237 (2005).

    Article  PubMed  Google Scholar 

  5. Lawrence, C., Howell, D. A., Conklin, D. E., Stefan, A. M. & Martin, R. F. Delayed pancreaticoduodenectomy for cancer patients with prior ERCP-placed, nonforeshortening, self-expanding metal stents: a positive outcome. Gastrointest. Endosc. 63, 804–807 (2006).

    Article  PubMed  Google Scholar 

  6. Halloran, C. M. et al. Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy. Br. J. Surg. 95, 453–459 (2008).

    Article  CAS  PubMed  Google Scholar 

  7. Balcom, J. H. 4th, Rattner, D. W., Warshaw, A. L., Chang, Y. & Fernandez-del Castillo, C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch. Surg. 136, 391–398 (2001).

    Article  PubMed  Google Scholar 

  8. Winter, J. M. et al. 1,423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J. Gastrointest. Surg. 10, 1199–1210 (2006).

    Article  PubMed  Google Scholar 

  9. Müller, S. A. et al. Vascular resection in pancreatic cancer surgery: survival determinants. J. Gastrointest. Surg. 13, 784–792 (2009).

    Article  PubMed  Google Scholar 

  10. Smith, R. A. et al. Preoperative resolution of jaundice following biliary stenting predicts more favorable early survival in resected pancreatic ductal adenocarcinoma. Ann. Surg. Oncol. 15, 3138–3146 (2008).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John P. Neoptolemos.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neoptolemos, J., Halloran, C. PBD—better stents in specialized centers are needed. Nat Rev Clin Oncol 7, 244–246 (2010). https://doi.org/10.1038/nrclinonc.2010.45

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2010.45

  • Springer Nature Limited

This article is cited by

Navigation